Article | June 22, 2022

How eConsent Can Help Legally Authorized Representatives In Clinical Trials

eConsent-Informed-tablet-iPad

A legally authorized representative (LAR) has a vital role to play in clinical trials, yet clinical trial software vendors too often forget to think about LARs and their needs. 

Most clinical research professionals have encountered patients who are in a coma or who have conditions like Alzheimer’s, dementia, serious mental illness, or developmental disabilities that prevent them from understanding and completing the informed consent process. 

In these cases, a Legally Authorized Representative (LAR) can sign on the patients’ behalf, in accordance with FDA or other national regulations. 

But in spite of how important LARs are to clinical trials, clinical trial software vendors often market their products exclusively to patients who can consent to and participate in trials themselves. Little or nothing is said about how the software can help Legally Authorized Representatives with informed consent.

With that in mind, we’ve put together this list of three ways eConsent can help LARs.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader